{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-011633","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.170238+00:00","generated_at":"2026-05-20T23:28:27.355051+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Protagenic Therapeutics exchanges 459,420 warrants for 367,544 shares at 0.8 ratio","bullets":["Warrant Exchange Agreement with unaffiliated holder to cancel 459,420 warrants for 367,544 common shares.","Exchange relies on Section 3(a)(9) exemption; shares issued without restrictive legends.","Transaction to be completed within six months of May 20, 2025.","Net reduction of 91,876 potential shares outstanding compared to exercise of warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-011633","json":"https://secwatch.observer/filing/0001641172-25-011633.json","markdown":"https://secwatch.observer/filing/0001641172-25-011633.md","text":"https://secwatch.observer/filing/0001641172-25-011633.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225011633/0001641172-25-011633-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225011633/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T23:28:27.355051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}